Surgical Oncology. Definition of Neoplasia. a disorder of cell growth in which there is a permanent and inherited change in cells resulting in a pathological proliferation of tissue. The Etiology of Cancer. Viruses(papilloma, Epstein-Barr, Hepatitis B, retroviruses,HIV) Radiation exposure
By doliView Direct invasion rectal cancer PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Direct invasion rectal cancer PowerPoint presentations. You can view or download Direct invasion rectal cancer presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.
Rectal cancer. OLD APPROACH TO RECTAL CANCER. CURRENT APPROACH TO RECTAL CANCER. Surgical resection Pathology assessment and estimation of risk Treatment based upon classical TNM factors Postoperative concurrent chemo-radiation. Staging workup (MRI,TRUS,PET CT) MDT discussion
They immediately put 74 cc back into me, via an IV drip. The remaining 6 cc will be expanded to increase the number of stem cells from approximately 5 million to 100-200 million. Half to all of the expanded cells will be put back into me again, via IV with the other half to be frozen for future use.
Cancer colo-rectal. FARA Régis Service de chirurgie viscérale Pr Y.P. LE TREUT IFSI 2008. Rappels. Anatomie Physiologie. Epidémiologie . 4 e cancer dans le monde, France à risque élevé > europe de l’est > Asie, Afrique et Amérique du Sud 1 er cancer en France ~ 15% des cancers
CANCER COLO- RECTAL. 1 er cancer digestif dans les pays industrialisés Âge moyen 65 ans Localisation: sigmoïde 45%, rectum 30% Pronostic médiocre: 40% survie à 5 ans Traitement multi-disciplinaire. Vascularisation et drainages lymphatiques.
Cancer Colo-rectal. « Bien comprendre le rapport du médecin…. et ensuite c’est facile! ». Jean Leclerc, MD AQTV, Nov. 2010. Petit Problème?. On en parle peu Pas « glamour » ou « sexy » Problème sérieux 3 e cancer en importance chez homme et femme Survie à 5 ans 60% (tout stage confondu)
Colo-rectal Cancer. Cancer Society Presentation. Chemotherapy Agents. Fluoropyrimidines 5FU, Capecitabine Oxaliplatin Irinotecan Mitomycin - C Targeted therapies Anti-angiogenic therapies: Bevacizumab EGFR inhibitors: Cetuximab, Panitumumab. Adjuvant therapy. Combination chemotherapy
Mediterranean School of Oncology Rome, November 23, 2012. Management of rectal cancer. CARMINE PINTO Oncologia Medica Policlinico S.Orsola-Malpighi Bologna. Background - 1.